Pro-Line XL Power Injectable Central Venous Catheter and Pro-Line XL Tunneler
Medical Components, Inc. · Decision date Oct 9, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 2026-10-09 for K260080, submitted by Medical Components, Inc. (Medcomp) of Harleysville, Pennsylvania. The filing covers the Pro-Line XL Power Injectable Central Venous Catheter and the Pro-Line XL Tunneler, classified under product code LJS within regulation 880.5970, the long-term (greater than 30 days) intravascular therapeutic catheter category, with a General Hospital review panel. The application was received 01/12/2026 as a traditional 510(k) and was not reviewed by a third party.
SESE means the submission was cleared as substantially equivalent to a legally marketed predicate device; it is not a PMA approval. The public record does not identify the predicate device, the specific modifications or components assessed, or the basis for the equivalence determination, and no summary statement is included in the available material. Whether the catheter and tunneler were reviewed as a system or separately is also not stated. The page was last updated 10/19/2026.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Oct 9, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260080
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Medical Components, Inc.
- Product code
- LJS
- Decision code
- SESE
- Decision date
- Oct 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days.
- Applicant
- Medical Components, Inc.
- Product code
- LJS
- FDA device class
- 2
FDA decision timeline
K260080 received
Application receipt date recorded by FDA.
K260080 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medical Components, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Harleysville, PA
Sources and methodology
- Original FDA record: K260080
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records